Sarcoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
D
Recruiting
  • Sarcoma
  • Hyperbaric Oxygen Therapy
  • Hyperbaric oxygen
  • Durham, North Carolina
    DUke University
2021-12-29
Dec 29, 2021
S
Recruiting
  • Lung Cancer
  • +10 more
  • ipilimumab +pembrolizumab +durvalumab
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
2021-12-28
Dec 28, 2021
N
Recruiting
  • Neurofibroma, Plexiform
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-01-07
Jan 7, 2022
I
Recruiting
  • Solid Tumors
  • +7 more
  • Scottsdale, Arizona
  • +12 more
2021-12-21
Dec 21, 2021
I
Completed
  • Sarcoma
  • Public Health intervention programme
  • No public Health intervention programme
  • (no location specified)
2021-11-08
Nov 8, 2021
T
Recruiting
  • Sarcoma
    • Dresden, Germany
    • +2 more
    2021-12-16
    Dec 16, 2021
    F
    Not yet recruiting
    • Clinical Stage I Cutaneous Melanoma AJCC v8
    • +33 more
    • Informational Intervention
    • +4 more
    • Los Angeles, California
    • +4 more
    2022-01-04
    Jan 4, 2022
    C
    Recruiting
    • Sarcoma
    • Radiosurgery
    • Caen, France
    • +10 more
    2022-01-05
    Jan 5, 2022
    N
    Recruiting
    • Clinical Stage IV Cutaneous Melanoma AJCC v8
    • +20 more
    • Pembrolizumab
    • Ziv-Aflibercept
    • Tampa, Florida
    • +8 more
    2022-01-05
    Jan 5, 2022
    W
    Recruiting
    • Wilms' Tumor
    • +5 more
    • Radiomic Algorithm
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    2021-12-16
    Dec 16, 2021
    H
    Recruiting
    • Sarcoma
    • Helsinki, Finland
      Helsinki University Central Hospital
    2021-12-31
    Dec 31, 2021
    N
    Recruiting
    • Glioblastomas
    • +4 more
    • Enhanced Mindfulness Intervention
    • Psychoeducation
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    2021-12-31
    Dec 31, 2021
    B
    Active, not recruiting
    • Sarcoma
    • Autologous HER2-specific T cells
    • +3 more
    • Houston, Texas
    • +1 more
    2021-12-09
    Dec 9, 2021
    B
    Recruiting
    • Sarcoma
    • HER-2 Protein Overexpression
    • cells
    • +3 more
    • Houston, Texas
      Texas Children's Hospital
    2021-12-08
    Dec 8, 2021
    M
    Recruiting
    • Sarcoma
    • +6 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    2021-12-28
    Dec 28, 2021
    M
    Not yet recruiting
    • Central Nervous System Neoplasm
    • +4 more
    • Smartphone Application
    • Houston, Texas
      M D Anderson Cancer Center
    2021-12-22
    Dec 22, 2021
    N
    Enrolling by invitation
    • Breast Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      2021-12-22
      Dec 22, 2021
      P
      Recruiting
      • Sarcoma
      • +6 more
      • Denver, Colorado
      • +5 more
      2021-12-17
      Dec 17, 2021
      M
      Recruiting
      • Sarcoma
      • +2 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      2021-12-16
      Dec 16, 2021
      U
      Recruiting
      • Sarcoma
      • Sarcoma Metastatic
      • Ann Arbor, Michigan
        University of Michigan Rogel Cancer Center
      2021-12-15
      Dec 15, 2021
      N
      Recruiting
      • Sarcoma
      • +4 more
        • Washington, District of Columbia
        • +3 more
        2021-12-15
        Dec 15, 2021
        N
        Active, not recruiting
        • Retinoblastoma
        • +2 more
          • Bethesda, Maryland
            National Cancer Institute (NCI), 9000 Rockville Pike
          2021-12-15
          Dec 15, 2021
          E
          Recruiting
          • Locally Advanced Solid Tumor
          • +16 more
          • Birmingham, Alabama
          • +30 more
          2021-12-13
          Dec 13, 2021